Bergenhem Nils 4
4 · CPEX Pharmaceuticals, Inc. · Filed Feb 1, 2010
Insider Transaction Report
Form 4
Bergenhem Nils
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2010-02-01+5,840→ 5,840 total→ Common Stock, $0.01 par value (5,840 underlying) - Award
Right to Purchase
2010-02-01$15.60/sh+17,500$273,000→ 17,500 totalExercise: $15.60Exp: 2020-02-01→ Common stock $0.01 par value (17,500 underlying)
Footnotes (3)
- [F1]Options were granted under terms of the Company's Amended and Restated 2008 Equity Incentive Plan. Grant becomes exercisable in three equal installments on 2/1/2011, 2/1/2012 and 2/1/2013.
- [F2]Each restricted stock unit represents a contingent right to receive one share of CPEX Pharmaceuticals, Inc. Common Stock, $0.01 par value.
- [F3]Restricted stock units were granted under terms of the Company's Amended and Restated 2008 Equity Incentive Plan. Units vest, and will be issued to the reporting person in three equal installments on 2/1/2011, 2/1/2012 and 2/1/2013.